Spero Therapeutics, Inc. Profile Avatar - Palmy Investing

Spero Therapeutics, Inc.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product can…

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SPRO's Analysis
CIK: 1701108 CUSIP: 84833T103 ISIN: US84833T1034 LEI: - UEI: -
Secondary Listings
SPRO has no secondary listings inside our databases.